|
||
“A Life-or-Death Situation.” By Robin Marantz Henig, The New York Times. As a bioethicist, Peggy Battin fought for the right of people to end their own lives. After her husband’s cycling accident, her field of study turned unbearably personal. Brooke was cycling down a hill in City Creek Canyon in Salt Lake City when . . . → Read More: A Life-or-Death Situation 
“Why We’re Losing the War on Cancer-and How to Win It.” The Leonard Lopate Show, WNYC. Journalist and cancer survivor Clifton Leaf looks at why we have made such limited progress fighting the disease. In The Truth in Small Doses: Why We’re Losing the War on Cancer-and How to Win It describes why the public’s . . . → Read More: Why We’re Losing the War on Cancer-and How to Win It
“Wouldn’t It Have Been Better Not To Get Cancer In The First Place?” By Dr. Susan Love, Dr. Susan Love Research Foundation. Dr. Susan Love was diagnosed with leukemia on June 8th, 2012. I have given a lot of thought to the collateral damage that results from cancer treatment. The fact is, it is rarely . . . → Read More: Wouldn’t It Have Been Better Not To Get Cancer In The First Place?
“Anxiety Lingers Long After Cancer.” By Jan Hoffman, The New York Times. From the shock of the cancer diagnosis onward, depression can take its well-documented toll on patients. Even patients who appear to pack away their fears during the grinding treatment journey to becoming cancer-free concede that when the regimen ends, they unspool emotionally. There . . . → Read More: Anxiety Lingers Long After Cancer
“Sharp Rise in Women’s Deaths From Overdose of Painkillers.” By Sabrina Tavernise, The New York Times. Prescription pain pill addiction was originally seen as a man’s problem, a national epidemic that began among workers doing backbreaking labor in the coal mines and factories of Appalachia. But a new analysis of federal data has found that . . . → Read More: Sharp Rise in Women’s Deaths From Overdose of Painkillers
“Breaking the Seal on Drug Research.” By Katie Thomas, The New York Times. PETER DOSHI walked across the campus of Johns Hopkins University in a rumpled polo shirt and stonewashed jeans, a backpack slung over one shoulder. An unremarkable presence on a campus filled with backpack-toters, he is 32, and not sure where he’ll be . . . → Read More: Breaking the Seal on Drug Research
“A Genetic Counselor Explains How Gene Patents Harmed Her Patients.” By Ellen Matloff, MS, Yale Cancer Center, Breast Cancer Action. Editor’s Note: On July 13, 2013, the Supreme Court ruled in our favor to overturn Myriad Genetics’ patents on the “breast cancer genes,” BRCA1 and BRCA2. We were proud to be the only breast cancer . . . → Read More: A Genetic Counselor Explains How Gene Patents Harmed Her Patients
“Our Genes, Their Secrets.” By Eleonore Pauwels, The New York Times. The Supreme Court’s unanimous ruling last Thursday, barring patents on human genes, was a wise and balanced decision that clears away a major barrier to innovation in the areas of biotechnology, drug development and medical diagnostics. But the decision is just a first step . . . → Read More: Our Genes, Their Secrets
“The Health Insurance Shell Game.” By Nortin M. Hadler and Janet Schwartz, Scientific American. The insurance industry had a rocky start a century ago. It was clear that there were untoward events that could befall any of us with catastrophic results, from the incineration of a home to the loss of the ability to maintain . . . → Read More: The Health Insurance Shell Game
“Susan G. Komen® Names Dr. Judith Salerno as President and Chief Executive Officer.” Susan G. Komen Press Release. A nationally known expert in both health policy and research has been named to lead Susan G. Komen, the world’s largest breast cancer organization, as its President and Chief Executive Officer. Susan G. Komen’s Board of Directors . . . → Read More: Susan G. Komen® Names Dr. Judith Salerno as President and Chief Executive Officer |
||
| Copyright © 2026 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||